Items Tagged with 'oncology'

Develop individualized treatment approaches for nonmetastatic CRPC based on efficacy and safety guidelines recommendations.

Describe the mechanisms of action of immune checkpoint inhibitors in cancer therapy.

Consider efficacy and safety profile of the therapeutic agent along with patient characteristics and molecular features of CLL to individualize therapeutic strategies in newly diagnosed CLL.

Screen patients for signs and symptoms of RRMM based on current criteria.

Identify the symptoms, classification, and stages of initial treatment for ALL.

This activity has been designed to address the educational needs of community and academic physicians specializing in hematology and hematology/oncology. It will also benefit other clinicians who manage patients with Castleman disease (CD).

Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents

Examine clinical evidence supporting the use of immune checkpoint inhibitors both as monotherapy and combination with chemotherapy or other immune agents